InvestorsHub Logo
Followers 61
Posts 3376
Boards Moderated 1
Alias Born 12/26/2012

Re: None

Friday, 01/02/2015 12:47:41 AM

Friday, January 02, 2015 12:47:41 AM

Post# of 130505
we believe it will be important to replenish our pipeline with strategically positioned programs that have the potential to deliver significant return on investment for the company, as LymPro has.



- See more at: http://www.thechairmansblog.com/amarantus-bioscience/gerald-commissiong/eltoprazine-lympro-manf-path-forward-value-creation/?utm_source=rss&utm_medium=rss&utm_campaign=eltoprazine-lympro-manf-path-forward-value-creation#sthash.BSFXCJnq.dpuf